NO994595L - Salt av naftyridin-karboksylsyrederivat - Google Patents

Salt av naftyridin-karboksylsyrederivat

Info

Publication number
NO994595L
NO994595L NO994595A NO994595A NO994595L NO 994595 L NO994595 L NO 994595L NO 994595 A NO994595 A NO 994595A NO 994595 A NO994595 A NO 994595A NO 994595 L NO994595 L NO 994595L
Authority
NO
Norway
Prior art keywords
salt
carboxylic acid
acid derivative
naphthyridine carboxylic
naphthyridine
Prior art date
Application number
NO994595A
Other languages
English (en)
Other versions
NO312515B1 (no
NO994595D0 (no
Inventor
Ae Ri Kim
Jin Hwa Lee
Ki Sook Park
Jong Ryoo Choi
Tae Hee Lee
Jay Hyok Chang
Do Hyun Nam
Hoon Choi
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of NO994595L publication Critical patent/NO994595L/no
Publication of NO994595D0 publication Critical patent/NO994595D0/no
Publication of NO312515B1 publication Critical patent/NO312515B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19994595A 1997-03-21 1999-09-21 Salt og tilknyttede hydrater av naftyridin- karboksylsyrederivat, fremgangsmåter for deres fremstilling,farmasöytiske sammensetninger innbefattende dem, og deresanvendelse i antibakteriell terapi NO312515B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970009840 1997-03-21
PCT/KR1998/000051 WO1998042705A1 (en) 1997-03-21 1998-03-20 Salt of naphthyridine carboxylic acid derivative

Publications (3)

Publication Number Publication Date
NO994595L true NO994595L (no) 1999-09-21
NO994595D0 NO994595D0 (no) 1999-09-21
NO312515B1 NO312515B1 (no) 2002-05-21

Family

ID=19500439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994595A NO312515B1 (no) 1997-03-21 1999-09-21 Salt og tilknyttede hydrater av naftyridin- karboksylsyrederivat, fremgangsmåter for deres fremstilling,farmasöytiske sammensetninger innbefattende dem, og deresanvendelse i antibakteriell terapi

Country Status (39)

Country Link
US (9) US7700617B2 (no)
EP (2) EP0981527B1 (no)
JP (3) JP3759962B2 (no)
KR (1) KR100266499B1 (no)
CN (1) CN1131229C (no)
AP (1) AP1331A (no)
AR (1) AR012125A1 (no)
AT (2) ATE239724T1 (no)
AU (1) AU726634B2 (no)
BG (1) BG63972B1 (no)
BR (1) BR9808290A (no)
CA (1) CA2283671C (no)
CZ (2) CZ288673B6 (no)
DE (2) DE69821147T2 (no)
DK (2) DK0981527T3 (no)
DZ (1) DZ2448A1 (no)
EA (1) EA001674B1 (no)
ES (2) ES2213669T3 (no)
HK (1) HK1026698A1 (no)
HU (2) HU225412B1 (no)
ID (1) ID22681A (no)
IL (2) IL131812A (no)
IN (1) IN188178B (no)
IS (2) IS2093B (no)
MA (1) MA24500A1 (no)
MY (1) MY137653A (no)
NO (1) NO312515B1 (no)
NZ (1) NZ337748A (no)
OA (1) OA11161A (no)
PE (1) PE67999A1 (no)
PL (1) PL191815B1 (no)
PT (2) PT1179533E (no)
SA (1) SA98181055B1 (no)
SI (2) SI1179533T1 (no)
SK (1) SK284107B6 (no)
TR (1) TR199902313T2 (no)
UA (1) UA56218C2 (no)
WO (1) WO1998042705A1 (no)
ZA (1) ZA982335B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
NZ514016A (en) * 1999-03-19 2001-09-28 Knoll Gmbh Treatment of osteoarthritis
US6262071B1 (en) 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
US6331550B1 (en) 1999-06-29 2001-12-18 Smithkline Beecham Corporation Methods of use of quinolone compounds against anaerobic pathogenic bacteria
US6803376B1 (en) 1999-06-29 2004-10-12 Smithkline Beecham Corporation Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
CA2282066C (en) 1999-06-29 2010-09-07 Smithkline Beecham Corporation Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
JP2001097891A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸器系病原菌に対するフルオロキノロン化合物の使用法
GR1003520B (el) * 1999-09-22 2001-01-22 Smithkline Beecham Plc Μεθοδος χρησης ενωσεων φλουοροκινολονης εναντια σε νοσοκομειακα αρνητικα κατα gramμ παθογενων βακτηριδιων
JP2001097864A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸管および尿路病原性細菌に対するフルオロキノリン化合物の使用方法
AU7709400A (en) * 1999-09-22 2001-04-24 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
JP2001097863A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 嫌気性病原菌に対するフルオロキノロン化合物の使用法
GR1003521B (el) * 1999-09-23 2001-01-22 Smithkline Beecham Plc Μεθοδοι χρησεως ενωσεων φλουοροκινολονης εναντια κατα gram θετικων παθογονων βακτηριδιων
KR20010091379A (ko) * 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
EP1412078B1 (en) 2001-08-02 2008-10-08 LG Life Sciences Limited Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one, gemifloxacin or a salt thereof
EP1458391B1 (en) * 2001-11-30 2007-09-05 LG Life Sciences Ltd. A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
EP2161270A1 (en) * 2005-06-15 2010-03-10 Hetero Drugs Limited Gemifloxacin hydrates
BRPI0708606A2 (pt) * 2006-03-07 2011-06-14 Wockhardt Ltd prà-fÁrmacos de Ácido benzoquinolizina-2-carboxÍlico
WO2010001408A2 (en) * 2008-06-06 2010-01-07 Matrix Laboratories Ltd. Novel polymorphic forms of gemifloxacin mesylate
WO2010146594A1 (en) * 2009-06-16 2010-12-23 Hetero Research Foundation Novel polymorphs of gemifloxacin mesylate
EP2491921A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Conservation of anhydrous form of gemifloxacin
SI3254681T1 (sl) * 2012-02-27 2019-10-30 Bristol Myers Squibb Co N-(5S,6S,9R)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5H-ciklo- hepta(B)piridin-9-IL-4-(2-okso-2,3-dihidro-1H-imidazo(4,5-B)piridin-1- IL)piperidin-1-karboksilatna sol
CZ2016104A3 (cs) * 2016-02-24 2017-09-06 Zentiva, K.S. Krystalické modifikace solí methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}fenyl)amino](fenyl)methyliden}-2-oxo-2,3-dihydro-1H-indol-6-karboxylátu a způsoby jejich přípravy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ES512969A0 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
IN162769B (no) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US4931446A (en) 1988-03-23 1990-06-05 Abbott Laboratories Antimicrobial for in-vitro diagnostic kits
US5286723A (en) 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
CA1336090C (en) 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
WO1991002526A1 (en) 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
WO1993025545A1 (en) 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
DK0688772T3 (da) 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US5776944A (en) 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
WO1996012704A1 (fr) 1994-10-20 1996-05-02 Wakunaga Seiyaku Kabushiki Kaisha Nouveau derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif
WO1996023775A1 (fr) 1995-01-30 1996-08-08 Wakunaga Seiyaku Kabushiki Kaisha Nouveaux derives d'acide pyridonecarboxylique ou de ses sels et agent antibacterien contenant ces derives en tant qu'ingredient actif
DK0789697T3 (da) 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
US20020032216A1 (en) * 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
KR19980080504A (ko) 1998-11-25
HUP0000728A2 (hu) 2000-09-28
CZ328299A3 (cs) 2000-02-16
IL131812A0 (en) 2001-03-19
CN1251101A (zh) 2000-04-19
BR9808290A (pt) 2000-05-16
US20130065917A1 (en) 2013-03-14
CN1131229C (zh) 2003-12-17
TR199902313T2 (xx) 1999-12-21
US20140187576A1 (en) 2014-07-03
MY137653A (en) 2009-02-27
EP1179533A3 (en) 2002-03-20
CA2283671A1 (en) 1998-10-01
NO312515B1 (no) 2002-05-21
PT1179533E (pt) 2004-05-31
US7700617B2 (en) 2010-04-20
IS2095B (is) 2006-04-12
HK1026698A1 (en) 2000-12-22
HUP0600401A3 (en) 2010-05-28
HUP0000728A3 (en) 2002-12-28
EA199900855A1 (ru) 2000-04-24
HU227536B1 (en) 2011-08-29
PL335812A1 (en) 2000-05-22
JP3759962B2 (ja) 2006-03-29
HU225412B1 (en) 2006-11-28
IL131812A (en) 2006-04-10
WO1998042705A1 (en) 1998-10-01
IS7952A (is) 2005-07-21
CZ288715B6 (cs) 2001-08-15
ES2198697T3 (es) 2004-02-01
ATE239724T1 (de) 2003-05-15
ATE257836T1 (de) 2004-01-15
AR012125A1 (es) 2000-09-27
DK1179533T3 (da) 2004-05-03
KR100266499B1 (ko) 2000-12-01
HU0600401D0 (en) 2006-07-28
DK0981527T3 (da) 2003-09-01
AU726634B2 (en) 2000-11-16
AP1331A (en) 2004-11-26
BG103750A (en) 2000-06-30
US20150291585A1 (en) 2015-10-15
US20170253588A1 (en) 2017-09-07
US20090182006A1 (en) 2009-07-16
PE67999A1 (es) 1999-09-30
US20080039488A1 (en) 2008-02-14
JP4781614B2 (ja) 2011-09-28
OA11161A (en) 2003-04-25
SK123699A3 (en) 2000-08-14
US20160264569A1 (en) 2016-09-15
DE69814378T2 (de) 2004-02-26
ES2213669T3 (es) 2004-09-01
DE69821147D1 (de) 2004-02-19
AU6636698A (en) 1998-10-20
DE69814378D1 (de) 2003-06-12
JP2000510484A (ja) 2000-08-15
CA2283671C (en) 2003-09-16
PT981527E (pt) 2003-09-30
DE69821147T2 (de) 2004-11-11
EP1179533A2 (en) 2002-02-13
UA56218C2 (uk) 2003-05-15
JP2004002413A (ja) 2004-01-08
US20100240694A1 (en) 2010-09-23
DZ2448A1 (fr) 2003-01-11
EP0981527B1 (en) 2003-05-07
ID22681A (id) 1999-12-09
IS5181A (is) 1999-09-14
SA98181055B1 (ar) 2006-10-11
IN188178B (no) 2002-08-31
JP2009051851A (ja) 2009-03-12
SK284107B6 (sk) 2004-09-08
PL191815B1 (pl) 2006-07-31
US20110312987A1 (en) 2011-12-22
EP0981527A1 (en) 2000-03-01
NZ337748A (en) 2001-03-30
MA24500A1 (fr) 1998-10-01
NO994595D0 (no) 1999-09-21
EA001674B1 (ru) 2001-06-25
IS2093B (is) 2006-04-12
ZA982335B (en) 1999-11-23
EP1179533B1 (en) 2004-01-14
SI1179533T1 (en) 2004-04-30
AP9901649A0 (en) 1999-09-30
BG63972B1 (bg) 2003-08-29
CZ288673B6 (cs) 2001-08-15
SI0981527T1 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
NO994595L (no) Salt av naftyridin-karboksylsyrederivat
HK1043124A1 (en) Salt of naphthyridine carboxylic acid derivative.
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
PL351898A1 (en) O-substituted derivatives of carboxylic acids
ATE228995T1 (de) Aminomethylcarbonsäurederivate
NO992245D0 (no) FremgangsmÕte for fremstilling av aminokarboksylsyrer
NO20002637L (no) FremgangsmÕte for fremstilling av 8-metoksy-kinolon- karboksylsyrer
ATE260657T1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
NO923508D0 (no) Bicykliske karboksylsyrederivater
FI960634A (fi) Uusia kinolonikarboksyylihappojohdannaisia
FI963050A (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
IS5009A (is) 3-Alkoxýísoxazól-4-ýl setin 2-amínó karboxýlsýru efnasambönd
AU7940598A (en) Quinolone carboxylic acid derivatives
PL335601A1 (en) Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
NO20021043D0 (no) Mellomprodukter for fremstilling av kinolonkarboksylsyre- derivater
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
NO308465B1 (no) FremgangsmÕte for fremstilling av karboksylsyrederivater
NO305838B1 (no) FremgangsmÕte og mellomprodukter for fremstilling av naftyridonkarboksylsyresalter
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
ID20291A (id) Asam-asam oksobutirat tersubstitusi sebagai penghamba-penghambat matriks metaloproteasa
GB9907082D0 (en) The preparation of carboxylic acid derivatives
BR1100402A (pt) Derivados do ácido quinolona carboxìlico
NO995678L (no) Fremgangsmåte for fremstilling av 5-okso-3-fenyl-3- cykloheksenkarboksylsyre
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
NO994977D0 (no) Fremstilling av enantiomerfrie biarylketokarboksylsyrer

Legal Events

Date Code Title Description
MK1K Patent expired